Diagnostic Imaging Pathways - Hypertension of Renovascular Cause

References

1. Krumme B, Blum U, Schwertfeger E, et al. Diagnosis of renovascular disease by intra- and extrarenal Doppler scanning. Kidney Int 1996;50:1288-92. (Level II/III evidence)
2. Radermacher J, Brunkhorst R. Diagnosis and treatment of renovascular stenosis - a cost-benefit analysis. Nephro Dial Transplant 1998;13:2761-7.
3. Boudewijn G, Vasbinder GBC, Neelmans PJ, Kessels AGH, et al. Diagnostic tests for renal artery stenosis in patients suspected of having renovascular hypertension: a meta-analysis. Ann Intern Med 2001;135:401-11. (Level I/II evidence). Click here to view reference
4. Radermacher J, Chavan A, Bleck J, et al. Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis. NEJM 2001;344:410-7. (Level I/II evidence). Click here to view reference
5. Krijnen P, Van Jaarsveld BC, Steyerberg EW, et al. A clinical prediction rule for renal artery stenosis. Ann Intern Med 1998;129:705-11. (Level II evidence). Click here to view reference
6. Pedersen EB. New tools in diagnosing renal artery stenosis. Kidney International 2000;57:2657-77.
7. Rankin SC, Saunders AJS, Cook GJR, et al. Renovascular Disease. Clinical Radiology 2000;55:1-12. (Review article)
8. Qanadli SD, Soulez G, Therasse E, et al. Detection of renal artery stenosis: prospective comparison of captopril-enhanced Doppler sonography, captopril-enhanced scintigraphy, and MR Angiography. AJR 2001;177:1123-29. (Level III evidence)
9. Van Jaarsveld BC, Krijnen P, Pieterman H, et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal artery stenosis. NEJM 2000;342:1007-14. (Level II evidence). Click here to view reference
10. Leertouwer TC, Gussenhoven EJ, Bosch JL, et al. Stent placement for renal arterial stenosis: where do we stand? A meta-analysis. Radiology 2000;216:78-85. (Level II evidence). Click here to view reference
11. Weibull H, Bergqvist D, Bergentz S-E, et al. Percutaneous transluminal renal angioplasty versus surgical reconstruction of atherosclerotic renal artery stenosis: a prospective randomized study. J Vas Surg 1993;18:841-52. (Level II evidence). Click here to view reference
12. Baumgartner I, von Aesch K, Do D-D, et al. Stent placement in ostial and nonostial atherosclerotic renal arterial stenoses: a prospective follow-up study. Radiology 2000;216:498-505. (Level II evidence). Click here to view reference
13. van de Ven PJ, Kaatee R, Beutler JJ, et al. Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: a randomised trial. Lancet 1999;353:282-86. (Level II evidence). Click here to view reference
14. Parker SC, Hannah A, Brooks M, et al. Renal artery stenosis: a disease worth pursuing. MJA 2001;175:149-53. (Clinical update)
15. Harward TR, Poindexter B, Huber TS, Carlton LM, Flynn TC, Seeger JM. Selection of Patients for Renal Artery Repair Using Captopril Testing. Am J Surg 1995;170:183-7. (Level III evidence)
16. Ramsay LE, Waller PC. Blood pressure response to percutaneous transluminal angioplasty for renovascular hypertension: an overview of published series. Br Med J 1990;300:569-72. (Level III evidence)
17. Ramos F, Kotliar C, Alvarez D, et al. Renal function and outcome of PRTA and stenting for atherosclerotic renal artery stenosis. Kidney International 2003;63:276-82. (Level II/III evidence)
18. Zeller T, Frank U, Muller C, et al. Predictors of Improved Renal Function After Percutaneous Stent-Supported Angioplasty of Severe Atherosclerotic Ostial Renal Artery Stenosis. Circulation 2003;108:2244-2249. (Level II evidence). Click here to view reference
19. Watson PS, Hadjipetrou P, Cox SV, Piemonte TC, Eisenhauer AC. Effect of Renal Artery Stenting on Renal Function and Size in Patients with Atherosclerotic Renovascular Disease. Circulation 2002;102:1671-77. (Level II evidence). Click here to view reference
20. Dworkin L, Cooper C. Renal-Artery Stenosis. N Engl J Med. 2009;361:1972-8.(Review Article).
21. Grobner T. Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant. 2006;21:1104-8. (Level II evidence). Click here to view reference
22. Wheatley K, Ives N, Gray R, Kalra P, Moss J, Baigent C, et al. Revascularization versus Medical Therapy for Renal-Artery Stenosis. N Engl J Med. 2009;361:1953-62.(Level I evidence)
23. Levy MS, Creager MA. Revascularization versus medical therapy for renal-artery stenosis. The ASTRAL Investigators. The New England Journal of Medicine 2009; 361: 1953--1962. Vasc Med. 2010 Aug;15(4):343-5. (Level I evidence)Click here to view reference
24. High WA, Ayers RS, Chandler J et al. Gadolinium is dectectable within the tissue of patients with nephrogenic systemic fibrosis. J am Acad Dermatol 2007; 56:21-26.(Level III evidence)
25. Boyd AS, Zic JA, Abraham JL. Gadolinium deposition in nephrogenic fibrosing dermopathy. J Am Acad Dermatol 2007; 56:27-30.(Review Article)
26. MRI Reference Group, Standards of Practice & Accreditation Commitee. RANZCR NSF Guidelines. October 2009.
27. Centers for Disease Control and Prevention (CDC). Nephrogenic fibrosing dermopathy associated with exposure to gadolinium-containing contrast agents--St. Louis, Missouri, 2002-2006. MMWR Morb Mortal Wkly Rep. 2007 Feb 23;56(7):137-41. (Level III evidence)Click here to view reference
28. Lim YL, Lee HY, Low SC, Chan LP, Goh NS, Pang SM. Possible role of gadolinium in nephrogenic systemic fibrosis: report of two cases and review of the literature. Clin Exp Dermatol. 2007 Jul;32(4):353-8.(Level IV evidence) Click here to view reference

Further Reading

1. Lee H-Y, Grant EG. Sonography in renovascular hypertension. J Ultrasound Med 2002;21:431-41.

File Formats

Some documents for download on this website are in a Portable Document Format (PDF). To read these files you might need to download Adobe® Acrobat Reader.